The abstract is read at the publisher; the summary is JClub's.
Recurrent weight gain after metabolic and bariatric surgery affects about 35% after sleeve gastrectomy and about 15% after Roux-en-Y gastric bypass within 5 years, rising to about one-third with longer follow-up.
- Why it matters: It is a major long-term obesity management challenge distinct from insufficient weight loss or suboptimal response, and no single factor fully explains it, limiting effective, tailored treatment.
- What they did: RWG is defined as regain of ≥25% of maximum weight lost assessed ≥24 months after surgery; randomized evidence supports procedure-linked differences and semaglutide use after MBS, while tirzepatide and combined strategies remain observational.
- The result: Phenotype- and procedure-specific escalation—from lifestyle optimization to obesity medications, endoscopic revision, and revisional surgery—may improve outcomes, and multimodal integrated approaches are suggested to better manage RWG.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.